Latent TB: Updated Treatment Recommendations
In this video CDC's Dr. LoBue discussing the updated recommendations for the 12-dose treatment regimen for latent TB infection.
In this video CDC's Dr. LoBue discussing the updated recommendations for the 12-dose treatment regimen for latent TB infection.
This video educates viewers on what the PrEP-to-Need Ratio is and how to properly use it to evaluate health equity.
This video walks through AIDSVu Location Profiles -- interactive, user-friendly summaries of HIV data for various locations across the U.S., including cities, counties, states, and regions. These profiles provide insights into HIV prevalence, new diagnoses, mortality, and more, helping users understand the impact of HIV in their communities.
This video discusses how congenital syphilis rates continue to rise, but many cases can be prevented with education and early screening.
This video explains the role of Pap smears in cervical health, highlighting that while they detect abnormal cell changes, they do not test for most STDs. It focuses on the connection between Pap smears and human papillomavirus (HPV), which is related to cervical cancer. The video emphasizes the importance of understanding the limitations of Pap smears and encourages discussing STD concerns with your healthcare provider for comprehensive testing.
This video provides a clear, detailed demonstration of the steps involved in administering and reading the Mantoux tuberculin skin test.
This video features Christopher Golden, a neonatologist at Johns Hopkins Children’s Center, discussing the alarming rise in congenital syphilis and its implications for pediatric care.
This video addresses the ongoing challenge of tuberculosis (TB) in Alaska, which has the highest TB rate in the United States. It emphasizes that TB can affect anyone and underscores the importance of awareness, testing, and treatment to help end TB in the state.
This video promotes the hepatitis B birth dose as a critical first step in protecting newborns from lifelong infection and liver cancer. It emphasizes that most people with hepatitis B are unknowingly infected at birth and that early vaccination is safe, effective, and the world’s first anti-cancer vaccine.